Metaproterenol
Back to searchMolecule Structure
Scientific Name
Metaproterenol
Description of the Drug
Orciprenaline is a beta-2 adrenergic agonist used to treat bronchospasm, asthma, and COPD.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00816
http://www.drugbank.ca/drugs/DB00816
Brand Name(s)
Not Available
Company Owner(s)
Usl Pharma Inc, Apotex Inc, Dey Lp, Heritage Pharma Labs Inc, Boehringer Ingelheim Pharmaceuticals Inc, Mylan Specialty Lp, American Therapeutics Inc, Watson Laboratories Inc, G And W Laboratories Inc, Muro Pharmaceutical Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Beta-2 adrenergic receptor | SINGLE PROTEIN | AGONIST | CHEMBL210 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL4270 | |
| PharmGKB | PA450390 | |
| Human Metabolome Database | HMDB0014954 | |
| DrugBank | DB00816 | |
| PubChem: Thomson Pharma | 14822465 | |
| PubChem | 4086 | |
| Mcule | MCULE-8722254342 | |
| LINCS | LSM-4318 | |
| Nikkaji | J6.736I | |
| BindingDB | 50295572 | |
| EPA CompTox Dashboard | DTXSID8048529 | |
| DrugCentral | 1720 | |
| ChemicalBook | CB1855195 | |
| Guide to Pharmacology | 7250 | |
| rxnorm | METAPROTERENOL SULFATE | METAPROTERENOL |
| KEGG Ligand | C07144 | |
| ChEBI | 83329 | 6792 |
